Abiopharma

Financial Statements and Related Announcement: Half Yearly Results

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm

SMMT Investors Have Opportunity to Lead Summit Therapeutics Inc. Securities Fraud Lawsuit with the Schall Law Firm

Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Turnstone Biologics Corp. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Turnstone Biologics Corp. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Turnstone Biologics Corp. - Common Stock. New value: Turnstone Biologics Corp. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Conduit Pharmaceuticals Inc. - Common Stock. New value: CDT Equity Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Conduit Pharmaceuticals Inc. - Warrant. New value: CDT Equity Inc. - Warrant.

Turnstone Biologics Corp (TSBX) was removed from the list of traded instruments on NASDAQ exchange

agilon health, inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - AGL

BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership

Smith+Nephew PLC Notification

Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations